CD27‐triggering on primary plasma cell leukaemia cells has anti‐apoptotic effects involving mitogen activated protein kinases
Open Access
- 12 January 2004
- journal article
- website
- Published by Wiley in British Journal of Haematology
- Vol. 124 (3), 299-308
- https://doi.org/10.1046/j.1365-2141.2003.04783.x
Abstract
Primary plasma cell leukaemia (PCL) is a rare plasma cell malignancy, which is related to multiple myeloma (MM) and is characterized by a poor prognosis. In a previous study we demonstrated that PCL plasma cells display a high expression of CD27, in contrast to MM plasma cells. The present study was set out to assess the functional properties of CD27 expressed on PCL plasma cells by triggering with its ligand CD70. Using CD27‐expressing purified plasma cells from a PCL patient we demonstrated that CD27‐triggering modestly inhibited spontaneous and dexamethasone‐induced apoptosis. In vitro stimulation and Western blotting showed that activation of p38 and extracellular‐regulated kinase 1/2 (ERK1/2) mitogen‐activated protein kinases (MAPK) was associated with CD27‐mediated signal transduction. Specific inhibition of p38 and ERK1/2 MAPK abolished the anti‐apoptotic effects of CD27‐triggering. Interestingly, simultaneous inhibition of p38 and ERK1/2 strongly sensitized PCL cells for dexamethasone‐induced apoptosis. Finally, in dexamethasone‐treated PCL cells, CD27‐triggering was associated with persistent DNA‐binding activity of activator protein 1 (AP‐1) but not of nuclear factor‐κB. These findings suggest that, in primary PCL, specific anti‐apoptotic pathways exist that might provide novel therapeutic targets.Keywords
This publication has 57 references indexed in Scilit:
- CD27: a memory B-cell markerImmunology Today, 2000
- One-way Cross-talk between p38MAPK and p42/44MAPKPublished by Elsevier ,1999
- Plasma Cell Generation from B-Lymphocytes via CD27/CD70 InteractionLeukemia & Lymphoma, 1999
- Control of lymphocyte function through CD27–CD70 interactionsSeminars in Immunology, 1998
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Interleukin-6 Inhibits Apoptosis of Malignant Plasma CellsCellular Immunology, 1995
- Primary plasma cell leukaemiaBritish Journal of Haematology, 1994
- CD27: marker and mediator of T-cell activation?Immunology Today, 1994
- CD27 expression by a distinct subpopulation of human B lymphocytesEuropean Journal of Immunology, 1990
- Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interactionCell, 1990